Research Paper Volume 16, Issue 2 pp 1021—1048
Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer
Figure 3. The genomic alterations of TFAP2A. (A) Details of TFAP2A genomic alterations in TCGA pan-cancer datasets; (B) The summary of TFAP2A genomic alterations in cancer cohort; (C) TFAP2A genetic mutations counts, types, and sites. (D) The correction of TFAP2A mRNA expression with main types of its genomic alterations; (E) The alteration frequency comparisons of TFAP2A related genes between TFAP2A altered and unaltered group.